Our partnering strategy is to combine our company strengths with the expertise of oncology and orphan companies to maximize the commercial opportunities of our novel products.
We selectively seek strategic relationships that will complement our internal efforts and product development strategies.
We are open to partnering inquiries about our products in development. If you are interested in exploring opportunities for collaborations or alliances, please contact us at the email below: bizdev@cbiolabs.com
http://www.cbiolabs.com/
http://www.cbiolabs.com/technology
http://www.cbiolabs.com/licensing_opportunities
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM